IDEXX 연구소, Inc.
DE ˙ XTRA ˙ US45168D1046
€490.30 ↑19.90 (4.23%)
2026-06-04
주가
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionKovack Advisors, Inc.
Latest Disclosed Ownership2,652 shares
Latest Disclosed Value $ 1,497,451
Kovack Advisors, Inc. reports 7.95% decrease in ownership of IX1 / IDEXX Laboratories, Inc.

On May 12, 2026 - Kovack Advisors, Inc. filed a 13F-HR form disclosing ownership of 2,652 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $1,294,176 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 17, 2026 disclosing 2,881 shares of IDEXX Laboratories, Inc.. This represents a change in shares of -7.95% during the quarter. The current value of the position is $1,300,276 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F IDEXX LABS COM 45168D104 2,652 -229 -7.95 1,497 -23.19 0.0799
2026-02-17 2025-12-31 13F/A-1 IDEXX LABS COM 45168D104 2,881 127 4.61 1,949 10.80 0.0906
2026-02-12 2025-12-31 13F IDEXX LABS COM 45168D104 2,881 127 1,966
2025-11-10 2025-09-30 13F IDEXX LABS COM 45168D104 2,754 -30 -1.08 1,760 17.82 0.1657
2025-08-04 2025-06-30 13F IDEXX LABS COM 45168D104 2,784 71 2.62 1,493 31.08 0.1464
2025-05-06 2025-03-31 13F IDEXX LABS COM 45168D104 2,713 0 0.00 1,139 1.61 0.1206
2025-02-05 2024-12-31 13F IDEXX LABS COM 45168D104 2,713 5 0.18 1,122 -18.06 0.1101
2024-11-05 2024-09-30 13F IDEXX LABS COM 45168D104 2,708 0 0.00 1,368 3.71 0.1449
2024-08-05 2024-06-30 13F IDEXX LABS COM 45168D104 2,708 57 2.15 1,319 -7.83 0.1452
2024-04-19 2024-03-31 13F IDEXX LABS COM 45168D104 2,651 26 0.99 1,431 -1.72 0.1733
2024-02-02 2023-12-31 13F IDEXX LABS COM 45168D104 2,625 2,625 1,457 0.1730
2023-10-19 2023-09-30 13F IDEXX LABS COM 45168D104 0 -1,484 -100.00 0 -100.00
2023-07-21 2023-06-30 13F IDEXX LABS COM 45168D104 1,484 84 6.00 745 6.58 0.0955
2023-04-21 2023-03-31 13F IDEXX LABS COM 45168D104 1,400 -107 -7.10 700 13.84 0.0954
2023-02-22 2022-12-31 13F IDEXX LABORATORIES ORD ORD 45168D104 1,507 -159 -9.54 615 13.08 0.0898
2022-11-14 2022-09-30 13F IDEXX LABORATORIES ORD ORD 45168D104 1,666 -489 -22.69 543 -28.17 0.0798
2022-08-10 2022-06-30 13F IDEXX LABORATORIES ORD ORD 45168D104 2,155 -625 -22.48 756 -50.26 0.0998
2022-05-16 2022-03-31 13F IDEXX LABORATORIES ORD ORD 45168D104 2,780 -280 -9.15 1,520 -24.57 0.1561
2022-01-18 2021-12-31 13F IDEXX LABORATORIES ORD ORD 45168D104 3,060 -171 -5.29 2,015 0.30 0.1947
2021-11-03 2021-09-30 13F IDEXX LABORATORIES ORD ORD 45168D104 3,231 -2,242 -40.96 2,009 -41.87 0.2183
2021-07-29 2021-06-30 13F IDEXX LABORATORIES ORD ORD 45168D104 5,473 -91 -1.64 3,456 26.92 0.3934
2021-05-04 2021-03-31 13F IDEXX LABORATORIES ORD ORD 45168D104 5,564 -3,259 -36.94 2,723 -38.25 0.3539
2021-01-14 2020-12-31 13F IDEXX LABORATORIES ORD ORD 45168D104 8,823 290 3.40 4,410 31.48 0.6347
2020-11-02 2020-09-30 13F IDEXX LABORATORIES ORD ORD 45168D104 8,533 9 0.11 3,354 19.19 0.5969
2020-07-31 2020-06-30 13F IDEXX LABORATORIES ORD ORD 45168D104 8,524 -737 -7.96 2,814 25.46 0.5478
2020-04-30 2020-03-31 13F IDEXX LABORATORIES ORD ORD 45168D104 9,261 193 2.13 2,243 -5.28 0.5180
2020-01-29 2019-12-31 13F IDEXX LABORATORIES ORD ORD 45168D104 9,068 -266 -2.85 2,368 -6.70 0.4233
2019-10-31 2019-09-30 13F IDEXX LABORATORIES ORD ORD 45168D104 9,334 655 7.55 2,538 6.19 0.5207
2019-08-14 2019-06-30 13F IDEXX LABS INC COM COM 45168D104 8,679 8,679 2,390 0.5463
2019-05-03 2019-03-31 13F IDEXX LABS INC COM COM 45168D104 0 -4,976 -100.00 0 -100.00
2019-02-06 2018-12-31 13F IDEXX LABS INC COM COM 45168D104 4,976 -1,753 -26.05 926 -44.88 0.2708
2018-10-09 2018-09-30 13F IDEXX LABS INC COM COM 45168D104 6,729 3,411 102.80 1,680 132.37 0.4332
2018-08-01 2018-06-30 13F IDEXX LABS INC COM COM 45168D104 3,318 42 1.28 723 15.31 0.2019
2018-05-15 2018-03-31 13F IDEXX LABS INC COM COM 45168D104 3,276 3,276 627 0.1573
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.